3D bioprinting as a designer organoid to assess pathological processes in translational medicine

Written by Olivia Seifert, Editor

Rameshwar R, Savanur VH, Etchegaray JP and Guvendiren M| Journal of 3D Printing in Medicine, 6(1) doi: 10.2217/3dp-2021-0006 (ePub ahead of print) (2022)  Keywords: bioinks • bioprinting • bone marrow • cancer • cancer models • drug screening • hematopoiesis • organoids • precision medicine  In summary, this paper discusses the advantages of 3D bioprinting for tumors and biological processes with a focus on bone morrow. These models may be important for diagnostics, drug development and rapid screening to ensure that emerging and current drugs are safe with minimum toxicity. Although there are increased commercial sources of 3D printers with user-friendly protocols,...

To view this content, please register now for access

It's completely free